A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments.
Fifteen brain tumor patients were treated with slow neutron. It proved to extend life span of terminal glioblastoma patients irresponsive to Co-60, to 2 years, but quality of survival is poor due to complications of previous treatments. Two glioblastoma patients excluding other treatments, the only genuine Boron-neutron capture therapy cases, have been living for 39+ and 34+ months working full-scale without neurological deficit.
D000328:Adult; D000368:Aged; D001345:Autoradiography; D001895:Boron / Q000032:analysis / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D002648:Child; D003037:Cobalt Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D004806:Ependymoma / Q000532:radiotherapy; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000532:radiotherapy; D008579:Meningioma / Q000532:radiotherapy; D008875:Middle Aged; D009502:Neutrons; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes; D001895:Boron